消化疾病周(DDW)日程
DDW Highlights
The Best of DDW 2014 Session
Tuesday, May 6, 2014, 2–4 p.m.
Moderators: J. Sumner Bell, III, MD, AGAF, DDW council treasurer, and Lawrence S. Friedman, MD,
DDW council chair
A discussant from each of the four societies will review the top presentations. Attend this not-to-be
missed session to get an overview of the latest, best and most thought provoking research presented
all week.
DDW Maintenance of Certification (MOC) Course
Tuesday, May 6, 2014, 1–5 p.m.
Course Director: Yolanda Scarlett, MD, and David Katzka, MD
Session Fee: $150
This live self-study course is designed around the AGA Guidebook to ABIM Recertification 2012 and
2013 modules. Each module has been approved by the American Board of Internal Medicine (ABIM)
for 10 MOC points. The format of this four-hour interactive course incorporates audienceresponse
technology to review two gastroenterology modules.
DDW Breakfast with the Experts
Sunday, May 4–Tuesday, May 6, 2014, 6:30–7:45 a.m.
Session Fee: $75
DDW’s popular Meet-the-Professors format is now offered in the morning, too. Just like the lunch
sessions, these are scholarly, dynamic discussions in an informal, small-group atmosphere. Breakfast
is included. Space is limited to 30 participants per session. View the objectives.
DDW Meet-the-Professor/Investigator Luncheons
Sunday, May 4–Tuesday, May 6, 2014, 12:30–1:45 p.m.
Session Fee: $75
Participate in a scholarly, dynamic discussion in an informal, small-group atmosphere. A boxed lunch
is included. Space is limited to 30 participants per session. View the objectives.
Poster Sessions and ePosters
Saturday, May 3–Tuesday, May 6, 2014, 8 a.m.–5 p.m.
Nearly 4,400 basic science, translational and clinical posters will be on display at DDW. Authors will be
at their posters to answer questions from noon until 2 p.m. on the day their posters are scheduled.
ePosters will return in 2014.
Poster Tours
Sunday, May 4 and Monday, May 5, 2014, 11–11:45 a.m.
Subject-matter experts from AGA, ASGE and SSAT will help you navigate the poster hall by leading
tours of the most significant research presented in six topic areas. Tour registration will open in March,
when accepted abstracts have been selected. There is no charge, but prior registration is
recommended to secure your spot.*
* If registration is full you can visit the “stand by” line in the Poster Hall.
Sunday, May 4
Tour Title: IBD (P01)
Society Lead: AGA
Moderator: Edward Loftus, MD, AGAF
Tour Title: ERCP (P02)
Society Lead: ASGE
Moderator: Andrew Wang, MD
Tour Title: Colon Rectal (P03)
Society Lead: SSAT
Moderator: Jennifer Holder-Murray, MD and Imran Hassan, MD
Monday, May 5
Tour Title: Eosinophilic Esophagitis (P04)
Society Lead: AGA
Moderator: Glenn Furuta, MD
Tour Title: Endoscopic Ultrasound (P05)
Society Lead: ASGE
Moderator: Subbaramiah Sridhar, MD, FASGE
Tour Title: Esophageal (P06)
Society Lead: SSAT
Moderator: Steven DeMeester, MD and James Dolan, MD
Diversity Reception
Monday, May 5, 2014, 6–7 p.m.
Jointly sponsored by all four societies, this reception provides a valuable networking opportunity for
minorities to gather, discuss relevant issues and learn more about what each society is doing to
promote diversity within gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Combined Clinical Symposia
Saturday, May 3–Tuesday, May 6, 2014
AASLD, AGA, ASGE and SSAT offer jointly-sponsored symposia on topics of broad interest to DDW
participants. The integrated, multi-disciplinary approach of these sessions will interest both clinicians
and basic scientists alike.
Date
Time
Title
Moderators
Sponsors
Saturday,
10–
Role of
Stephen
AASLD,ASGE, AGA
May 3
11:30
Endoscopy in
Caldwell, MD;
a.m.
the Patient with
Shiv Sarin, MD,
Liver Disease
DM
Saturday,
2–3:30
Anticoagulation
Alan Barkun,
May 3
p.m.
Issues Around
MD, CM, MSc,
the Time of
FASGE; Klaus
Endoscopy:
Mergener, MD,
Management in
PhD,MBA,
an Era of
FASGE; K.
Expanding
Rajender Reddy,
Therapies
MD
Saturday,
4–5:30
Does Bariatric
Paul Berk, MD;
May 3
p.m
Surgery Have a
Ali Tavakkoli,
Role in
MD; Lee Kaplan,
Managing
MD, PhD
ASGE, AGA, AASLD
AASLD, AGA, SSAT
Nonalcoholic
Fatty Liver
Disease?
Sunday,
8–9:30
Endoscopic
David Rubin,
AASLD, SSAT, AGA,
May 4
a.m.
Evaluation and
MD; Francis
ASGE
Surveillance of
Farraye, MD,
IBD
MSc; Loren
Laine, MD,
AGAF
Sunday,
10–
Prevention of
C. Mel Wilcox,
May 4
11:30
Post-ERCP
MD; Christopher
a.m.
Pancreatitis
Forsmark,
AGA, ASGE
MD, AGAF;
Stuart Sherman,
MD
Sunday,
2–3:30
Advances and
Alessandro
May 4
p.m.
Controversies
Fichera, MD;
SSAT, AGA, ASGE
in Management
Imran Hassan,
of Locally
MD; Patrick
Advanced
Lynch, MD
Rectal Cancer
Monday,
10–
Severe Colitis:
Amar
May 5
11:30
More
Deshpande, MD;
a.m.
Medicines or
Najjia Mahmoud,
Time for
MD; John
Surgery?
Pemberton
Monday,
2–3:30
Prevention and
Christina
May 5
p.m.
Treatment of
Ferrone, MD;
Postsurgical
Thomas Aloia,
Bile Leaks
MD; Richard
AGA, SSAT
SSAT, ASGE, AGA
Kozarek, MD,
FASGE
Monday,
4–5:30
Endoscopic
Paul Tarnasky,
AASLD, SSAT, AGA,
May 5
p.m.
Tools to
MD; Todd
ASGE
Diagnose
Baron, MD,
Hepatobiliary
FASGE; Jeffrey
Malignancy
Marks, MD,
FASGE
Tuesday,
8–9:30
Practical
Michelle
May 6
a.m.
Approach to
Anderson, MD,
Managing
MSc, FASGE;
Pancreatic
Carlos
Cysts
Fernandez-del
ASGE, AGA, SSAT
Castillo, MD;
Marcia Canto,
MD, MHS
Tuesday,
10–
Evaluation and
Matthew Katz,
May 6
11:30
Approaches for
MD; Mark
a.m.
Borderline
Callery, MD;
Resectable
Michael
Pancreas
Kochman, MD,
Cancer
AGAF
Tuesday,
2–3:30
Barrett’s
Stephen
May 6
p.m.
Consensus
DeMeester, MD;
SSAT, ASGE, AGA
AGA, ASGE, SSAT
Conference
Kenneth Wang,
MD, FASGE;
Prateek Sharma,
MD
Combined Translational Symposium
Monday, May 5, 2014, 10–11:30 a.m.
The Future of FMT — Promise and Challenges for Technologies of the Future
Moderators: Gary Wu, MD, and Brent Tetri, MD
Meet-the-Professor/Investigator Sessions Learning
Objectives
Sunday Sessions, 12:30–1:45 p.m.
Session Title: Enteric Microflora and Functional Bowel Disorders (M01)
Presenter: Yehuda Ringel
Learning Objectives: Coming Soon.
Session Title: Molecular Mechanisms of IBD (M02)
Presenter: John H. Kwon
Learning Objectives: Participants will be able to:

Understand aspects of host-microbe interactions.

Recognize the contribution of autophagy in IBD pathogenesis.
 Understand aspects of epigenetic regulation of IBD.
Session Title: Chromoendoscopy for IBD Surveillance: How It's Done (M03)
Presenter(s): Ralf Kiesslich and Roy M. Soetikno
Learning Objectives: Participants will be able to:

Understand different types of intravital staining.

Understand the way and route of administration.
 Understand the identification of flat lesions and interpretation of different staining patterns.
Session Title: Difficult Decisions in GI Bleeding: A Case-Based Discussion (M04)
Presenter(s): John R. Saltzman and Lisa L. Strate
Learning Objectives: Participants will be able to:

To be able to identify high risk patients and provide optimal initial management for patients with
upper GI bleeding.

To know the recommended timing and role of endoscopic therapy for control of upper GI
bleeding.

To understand the pros and cons of colonoscopy and radiologic interventions for acute lower
gastrointestinal bleeding.
Session Title: Difficult Problems in ERCP: A Case-Based Approach (M05)
Presenter(s): Oleh Haluszka and V. Raman Muthusamy
Learning Objectives: Participants will be able to:

Understand papillary anatomy and methods to achieve selective biliary and pancreatic duct
cannulation.

Prioritize techniques to identify and cannulate the hidden• papilla.
 Enumerate the array of therapeutic options to remove challenging biliary stones.
Session Title: Endoscopic Evaluation and Management of Sub-Epithelial Lesions (M06)
Presenter(s): Joo Ha Hwang and Girish Mishra
Learning Objectives: Coming Soon.
Session Title: EoE (M07)
Presenter: Gary W. Falk
Learning Objectives: Participants will be able to:

Understand the importance of separating out PPI-responsive esophageal eosinophilia from
eosinophilic esophagitis.

Understand the importance of esophageal remodeling especially in untreated and unrecognized
eosinophilic esophagitis.
 Develop a plan for optimal management of eosinophilic esophagitis patients.
Session Title: Expert Polypectomy (M08)
Presenter(s): Vinay Chandrasekhara and Gottumukkala S. Raju
Learning Objectives: Participants will be able to:

Recognize and describe morphologic features of colon polyps suggestive of submucosal
invasion.

Describe techniques associated with endoscopic resection (traditional EMR, ligation-assisted
EMR, ESD).

Learn about the current tools for EMR and ESD including the various snares, submucosal
injectates, knives and electrosurgical processors.
Session Title: FMT: Challenges, Obstacles, and Future Horizons (M09)
Presenter: Colleen Kelly
Learning Objectives: Participants will be able to:

Identify patients who are appropriate candidates for fecal microbiota transplantation (FMT).

Develop an FMT protocol: including, donor identification and screening, informed consent and
administration method.

Understand obstacles to widespread use of FMT including: regulatory and reimbursement
issues, source of donor material, and questions about safety.
Session Title: Gastroparesis (M10)
Presenter: Kenneth L. Koch
Learning Objectives: Participants will be able to:

List six categories of gastroparesis.

Describe treatment for functional obstructive gastroparesis.
 Describe diet and drug treatments for gastroparesis.
Session Title: Nutritional Management of IBD (M11)
Presenter(s): Ashwin N. Ananthakrishnan
Learning Objectives: Participants will be able to:

Identify dietary triggers of disease onset and relapse in IBD.

Identify predictors and consequences of nutritional deficiency in IBD.

Understand the role of nutrition (enteral and parenteral) in the management of inpatient and
outpatient IBD.
Session Title: Pitfalls and Pearls in Esophageal Function Testing (M13)
Presenter: John E. Pandolfino
Learning Objectives: Participants will be able to:

Determine which test is best suited to evaluate the patient with refractory reflux symptoms.

Analyze and interpret high-resolution manometry and pH-impedance.
 Utilize esophageal function tests to inform treatment options.
Session Title: Screening and Management of Cholangiocarcinoma (M14)
Presenter: Gregory J. Gores
Learning Objectives: Participants will be able to:

Identify the 3 subtypes of cholangiocarcinoma.

Understand the risk of cholangiocarcinoma in PSC.
 Apply treatment algorithms to cholangiocarcinoma.
Session Title: Screening and Surveillance for Pancreatic Cancer in High Risk Groups (M15)
Presenter: Randall Brand
Learning Objectives: Participants will be able to:

Identify those patients who are at high risk for developing pancreatic cancer.

Recommend how a high risk patient should be screened for pancreatic cancer.
 Recognize the risks, benefits and limitations of pancreatic cancer screening.
Session Title: Transitioning the Adolescent Liver Patient to Adult Care (M16)
Presenter: Shikha S. Sundaram
Learning Objectives: Participants will be able to:

Participants should understand why transition of care is important and how it is different from
transfer of care.

Participants should understand key elements of a successful transition.

Participants should understand when transition should take place and the challenges therein.
Back to Meet-the-Professor/Investigator Luncheons
Monday Sessions, 12:30–1:45 p.m.
Session Title: Celiac Disease: From a Rare Disease to a Public Health Problem (M17)
Presenter: Alessio Fasano
Learning Objectives: Participants will be able to:

Review the past and present epidemiological data on celiac disease worldwide.

Highlight the difficulties of self-diagnosis secondary to the current popularity of the gluten free
diet.

Discuss challenges and future opportunities in diagnosis, management, and prevention of celiac
disease.
Session Title: Fecal Transplantation in Pediatrics: False Start or Ready To Go With It? (M18)
Presenter: Stacy A. Kahn
Learning Objectives: Participants will be able to:

Understand the rationale for fecal microbiota transplantation (FMT).

Discuss the indications and evidence for FMT in pediatrics.
 Recognize the challenges surrounding FMT in pediatric patients.
Session Title: Update on Pediatric Motility Disorders: What Is New In Testing and Treatment? (M19)
Presenter: Carlo Di Lorenzo
Learning Objectives: Participants will be able to:

Gain knowledge about novel tests for motility disorders in children.

Learn about therapeutic options for children with functional and motility disorders.

Integrate this information in the evaluation and treatment of children with suspected motility
disorders.
Session Title: Acute Pancreatitis: Endoscopic Management of Complications (M20)
Presenter(s): Andrew S. Ross and Richard A. Kozarek
Learning Objectives: Participants will be able to:

Clearly identify the difference between the types of fluid collections arising in patients with acute
pancreatitis.

Understand the approach to management of patients with symptomatic or infected walled off
necrosis.
 Understand the role for ERCP in acute pancreatitis.
Session Title: Advanced ERCP: Lessons from the Masters (M21)
Presenter(s): John A. Martin and Gregory B. Haber
Learning Objectives: Coming Soon.
Session Title: Barrett's Esophagus: Whom and How to Ablate (M22)
Presenter(s): Virender Sharma and David E. Fleischer
Learning Objectives: Participants will be able to:

Understand guidelines for endoscopic treatment of Barrett's.

Understand techniques of endoscopic therapy for Barrett's.
 Understand controversies regarding endoscopic therapy of Barrett's.
Session Title: Diagnostic and Therapeutic Endoscopy in IBD (M23)
Presenter(s): Julia J. Liu and Bo Shen
Learning Objectives: Participants will be able to:

Be familiar with classification systems of IBD-related strictures, fistulae, and anastomotic sinus.

Be familiar with principles and techniques of endoscopic therapy for stricture, fistulae and sinus.

Be familiar with the identification and management of endoscopy procedure associated
complications.
Session Title: Experts in Enteroscopy: Who, What Device, and How? (M24)
Presenter(s): Adam C. Stein, Patrick Okolo, and Carol E. Semrad
Learning Objectives: Participants will be able to:

Know the indications for small bowel endoscopy.

Know the devices and tools available for small bowel endoscopy and therapeutics.

Learn the pearls and pitfalls in the diagnosis and management of small bowel bleeding, mass,
and ulcerating lesions.
Session Title: How Image Enhancement Can Help in Diagnosis and Management of Endoscopic
Lesions (M25)
Presenter: Tonya Kaltenbach
Learning Objectives: Coming Soon.
Session Title: Intestinal Ion Transport and Clinical Applications in Diarrheal Diseases and
Constipation (M26)
Presenter: Fayez K. Ghishan
Learning Objectives: Participants will be able to:

Learn basic mechanisms of intestinal transport.

Learn the effect of inflammatory cytokines on intestinal transport.
 Correlate changes in intestinal transport with clinical disorders.
Session Title: Keeping Your Cirrhotic Patient Alive (M27)
Presenter: Mark W. Russo
Learning Objectives: Participants will be able to:

Recognize treatment for ascites and its complications that may improve survival.

Identify risk factors for hepatorenal syndrome that increase mortality.
 Implement best practices for screening for hepatocellular carcinoma.
Session Title: Management of the HCV/HIV Co-Infected Patient (M28)
Presenter(s): Richard K. Sterling and Mandana Khalili
Learning Objectives: Participants will be able to:

Understand options available to assess the severity of liver disease (liver biopsy vs
non-invasive assessment).

Understand current options available for HCV treatment in patients with HIV coinfection.
 How to prioritize HCV treatment initiation.
Session Title: Management of Variceal Bleeding (M29)
Presenter: James Trotter
Learning Objectives: Participants will be able to:

Understand the current management of variceal bleeding.

Recognize how to implement emerging therapies for variceal bleeding.
 Recognize the spectrum of treatments for variceal bleeding.
Session Title: New Therapies for Chronic Constipation (M30)
Presenter: Darren M. Brenner
Learning Objectives: Participants will be able to:

Develop an appropriate algorithm for treating chronic idiopathic constipation.

Define and utilize FDA approved treatments for opioid-induced constipation.

Differentiate between appropriate therapies for slow-transit constipation and dyssynergic
defecation.
Session Title: Telemanagement of IBD (M31)
Presenter: Raymond Cross
Learning Objectives: Participants will be able to:

Characterize the burden of telephone calls in the care of patients with IBD.

Identify clinical factors and outcomes associated with high volume telephone encounters in the
care of patients with IBD.
 Describe telemedicine interventions used in the care of patients with IBD.
Session Title: The Microbiome and the Upper GI Tract (M32)
Presenter: Eamonn M. Quigley
Learning Objectives: Participants will be able to:

Know the general principles of the normal microbial population of the upper GI tract.

Enumerate common GI disorders related to an altered upper GI tract microbiota.

Be able to develop a therapeutic strategy to address disorders related to an altered upper GI
tract microbiota.
Session Title: Writers Workshop 1 Tips and Pitfalls in Writing and Editing Your Manuscript (M33)
Presenter(s): Michael G. Sarr and Jennifer F. Tseng
Learning Objectives: Participants will be able to:

Address the various types of submissions with their strengths and limitations.

Select the most applicable journal to target during submission.

Understand from an editors standpoint- what to avoid/ what to include and what is the "kiss of
death."
Back to Meet-the-Professor/Investigator Luncheons
Tuesday Sessions, 12:30–1:45 p.m.
Session Title: Genetics of IBD (M34)
Presenter: Judy Cho
Learning Objectives: Participants will be able to:

Define the major pathways associated with IBD and understand how these pathways inform
new therapeutic targets.

To define the role of common rare genetic variation in IBD and what implications this may have
for clinical exome sequencing.

To understand the differences in IBD-associated genetic architecture between varius
populations and what impact this will have in clinical practice.
Session Title: Stem Cells and Differentiation Pathways (M35)
Presenter: Noah F. Shroyer
Learning Objectives: Participants will be able to:

Synthesize data regarding multiple types of gastrointestinal stem cells to understand their
relationship with each other.

Understand how multiple different signaling pathways interact to regulate stem cell behavior.

Understand current and future areas of investigation into stem cells and differentiation
pathways.
Session Title: Complications, Tribulations and Challenges in Anorectal Surgery. What Have We
Learned? (M36)
Presenter: Paul E. Wise
Learning Objectives: Participants will be able to:
Session Title: Diagnosis and Management of Pancreatic Cystic Lesions (M37)
Presenter(s): Harry R. Aslanian and Jennifer S. Chennat
Learning Objectives: Participants will be able to:

Understand the diagnostic features that distinguish between types of pancreas cysts.

Understand features associated with an increased risk of malignant progression for mucinous
pancreas cysts.
 Review current management guidelines for pancreas cysts.
Session Title: Emerging Endoscopic Therapies for Obesity and Diabetes (M39)
Presenter: Christopher C. Thompson
Learning Objectives: Coming Soon.
Session Title: Enteral Nutrition for Nutrition and Decompression: When, Which One and How? (M40)
Presenter(s): John C. Fang and Stephen A. McClave
Learning Objectives: Participants will be able to:

Understand the indications and methods for using percutaneous feeding tubes for
decompression of the GI tract.

Learn the proper timing and route for enteral nutrition support.
 Know the different types of enteral feeding tubes and how to place them.
Session Title: Irritable Bowel Syndrome (M41)
Presenter: Lin Chang
Learning Objectives: Participants will be able to:

Implement the diagnostic criteria for IBS and an appropriate diagnostic evaluation.

Integrate and understand the multifactorial factors that contribute to the pathophysiology of IBS.

Determine the optimal treatment approach for IBS patients based on scientific evidence and
clinical experience.
Session Title: Large Polyp Resection (M42)
Presenter: Michael J. Bourke
Learning Objectives: Participants will be able to:

Describe endoscopic methods of assessing large colorectal lesions.

Discuss techniques for safe and effective endoscopic resection of large colorectal lesions.

Explain methods for early detection of those at risk for complications and techniques for
prevention and treatment.
Session Title: Minimal Hepatic Encephalopathy (M43)
Presenter(s): Jasmohan S. Bajaj and Kevin D. Mullen
Learning Objectives: Participants will be able to:

Determine the importance of minimal HE in the lives of patients and families.

Evaluate currently available strategies to diagnose minimal HE.

Learn about the management options available for minimal HE.
Session Title: New Therapies in GERD (M44)
Presenter: Michael F. Vaezi
Learning Objectives: Participants will be able to:

Discuss trend in diagnosing and treating GERD.

Review why patients do not respond to acid suppressive therapies.

Overview current strategies in managing patients who may not respond to traditional GERD
therapies.
Session Title: Pancreatitis In Children – Update On Management (M45)
Presenter: Uzma Shah
Learning Objectives: Participants will be able to:

Understand the basic pathophysiology of disease.

Understand medical management of pancreatitis.
 Learn about surgical options in treatment.
Session Title: Polyposis Syndromes (M46)
Presenter: Lisa A. Boardman
Learning Objectives: Participants will be able to:

Review the different approaches to distinguishing the main polyposis syndrome.

Learn how to manage the most common polyposis syndromes.

Discuss genetic evaluation and its role in prevention and treatment strategies in polyposis
syndromes.
Session Title: Writers Workshop 2 Key Points in Submitting and Revising Your Manuscript (M47)
Presenter(s): Susan Galandiuk and Steven C. Stain
Learning Objectives: Participants will be able to:

Learn how to maximize chances of manuscript acceptance.

Identify common causes of manuscript rejection.

Learn formatting of response to critiques that will make reviewers look more favorably on
resubmitted manuscripts.
Back to Meet-the-Professor/Investigator Luncheons
Breakfast with the Experts Learning Objectives
Sunday Sessions, 6:30–7:45 a.m.
Session Title: Barrett's Neoplasia 101: Techniques for Improving Detection, EMR and Ablation (BE01)
Presenter(s): Gary W. Falk and Charles J. Lightdale
Learning Objectives: Participants will be able to:

Learn the best and latest methods for detection of early cancer in Barrett's esophagus.

Comprehend the importance of endoscopic mucosal resection for early neoplasia in Barrett's
esophagus prior to employing other ablation techniques.

Understand the various methods available for ablation of Barrett's esophagus and the evidence
for safety and efficacy.
Session Title: Endomicroscopy for Beginners (BE02)
Presenter(s): Sharmila Anandasabapathy and Herbert C. Wolfsen
Learning Objectives: Participants will be able to:

Review limitations of current endoscopic screening and surveillance strategies including
endoscopic imaging, biopsy protocols and histologic analysis.

Discuss optical physics underlying confocal laser endomicroscopy (CLE) and volumetric laser
endomicroscopy (VLE).

Review clinical results using Endomicroscopy, especially in pre-malignant mucosal diseases,
such as Barrett's disease and colon polyps.
Session Title: EUS: State of the Art (BE03)
Presenter(s): Brintha K. Enestvedt and Raquel E. Davila
Learning Objectives: Participants will be able to:

Discuss the role of EUS in the management of pancreatic cysts.

Understand the utility of EUS in the evaluation of submucosal gastrointestinal lesions.

Address several debates in the role of EUS in cancer staging (i.e obstructing esophageal
lesions, early esophageal cancer, work up of indeterminate biliary strictures and
cholangiocarcinoma).
Session Title: Evaluation of the Pancreatic Mass (BE04)
Presenter(s): Dayna S. Early and Vanessa M. Shami
Learning Objectives: Participants will be able to:

To identify the differential diagnoses of pancreatic masses.

To discuss the best imaging modalities for characterization of pancreatic masses.

Acquire knowledge and demonstrate the best sampling methods for the diagnosis of pancreatic
masses.
Session Title: Paraesophageal Hernia: Where We Have Been, What We Are Doing Now (BE05)
Presenter(s): Jeffrey H. Peters , Nathaniel J. Soper, and Brant K. Oelschlager
Learning Objectives: Participants will be able to:

Understand the challenges of PEH repair.

Describe the steps of laparoscopic PEH repair.
 Discuss the controversial areas of PEH repair.
Session Title: Patient Reported Outcomes in IBD (BE06)
Presenter(s): Corey A. Siegel
Learning Objectives: Participants will be able to:

Define the importance of patient reported outcomes in clinical practice and as a research
endpoint.

Discuss the priority of the most important outcomes to patients.
 Determine how to create a treatment plan based on patient centered outcomes.
Session Title: Treatment of Hepatitis C: Use of Newly Approved Drugs (BE07)
Presenter: Nancy Reau
Learning Objectives: Participants will be able to:

Understand the treatment algorithm for both sofosbuvir (SOF) and simeprevir (SMV) use.

Recognize drug interactions and anticipate side effects of SMV and SOF.

Recognize populations appropriate for these agents and where these agents remain unstudied
or contraindicated.
Back to Breakfast with the Experts
Monday Sessions, 6:30–7:45 a.m.
Session Title: Biliary and Luminal Stents: Who, Which One, How, and How to Minimize Complications
(BE08)
Presenter(s): William M. Tierney and Peter D. Siersema
Learning Objectives: Participants will be able to:

Identify appropriate indications for biliary and lumincal stenting.

Discuss technical considerations for biliary and luminal stenting.
 Review methods to minimize complications of endoluminal stenting.
Session Title: Colonoscopy: Improving Your Technique (BE09)
Presenter: John L. Petrini
Learning Objectives: Participants will be able to:

Improve their ability to complete an examination safely and comfortably.

Recognize difficult situations and plan appropriately to reduce potential complications.
 Utilize techniques to improve efficiency in performing colonoscopy.
Session Title: Endoscopic Management of Chronic Pancreatitis (BE10)
Presenter: Stuart Sherman
Learning Objectives: Participants will be able to:

Understand the settings in chronic pancreatitis where endoscopic therapy is applied.

Know the endoscopic techniques used to treat chronic pancreatitis.
 Compare the results of endoscopic and surgical therapy of chronic pancreatitis.
Session Title: Is it ASH or is it NASH (BE11)
Presenter: Brent A. Neuschwander-Tetri
Learning Objectives: Participants will be able to:

Understand the pathophysiological similarities and differences between NASH and alcoholic
liver disease.

Understand the histological similarities and differences between NASH and alcoholic liver
disease.
 Understand the current data regarding alcohol consumption and NASH.
Session Title: Nausea and Vomiting (BE12)
Presenter: Kenneth L. Koch
Learning Objectives: Participants will be able to:

Develop a practical differential diagnosis for nausea and vomiting.

Describe mechanisms of nausea and vomiting.
 List drugs, diets, and devices to treat nausea and vomiting.
Session Title: Surgical Options and Solutions for the Treatment of Chronic Pancreatitis (BE13)
Presenter(s): William H. Nealon, Nicholas J. Zyromski, and David B. Adams
Learning Objectives: Participants will be able to:

Discuss role of surgical drainage procedures in managing chronic pancreatitis.

Review use of resection procedures in the management of chronic pancreatitis.

Assess indications for total pancreatectomy with islet auto transplantation in the management of
chronic pancreatitis.
Session Title: Tricks, Tips and Timing for the Difficult Cholecystectomy (BE14)
Presenter(s): Benjamin K. Poulose and Nathaniel J. Soper
Learning Objectives: Participants will be able to:

Understand the conditions rendering cholecystectomy more complex.

Discuss technical points that may facilitate the difficulties of cholecystectomy.

Describe the optimal timing for operating in acute choleystitis.
Back to Breakfast with the Experts
Tuesday Sessions, 6:30–7:45 a.m.
Session Title: Colonoscopy: Optimizing Your Technique (BE15)
Presenter: Jerome D. Waye
Learning Objectives: Participants will be able to:

Pass the scope through a difficult sigmoid colon.

Negotiate the hepatic flexure.
 Successfully remove large and complex polyps.
Session Title: ERCP and EUS in the Management of Acute and Chronic Pancreatitis (BE16)
Presenter(s): Douglas K. Pleskow and Christopher E. Forsmark
Learning Objectives: Coming Soon.
Session Title: Mastering ERCP (BE17)
Presenter: David L. Carr-Locke
Learning Objectives: Participants will be able to:

Employ current technologies and techniques to achieve safe and effective ERCP.

Be familiar with current procedures for therapy of a wide variety of biliary and pancreatic
disorders.
 Manage the risks and complications of ERCP-related adverse events.
Session Title: Pregnancy and IBD (BE18)
Presenter: Uma Mahadevan
Learning Objectives: Participants will be able to:

Prescribe appropriate IBD medications in pregnancy.

Prescribe appropriate IBD medications during lactation.
 Order appropriate diagnostic tests in the flaring pregnant IBD patient.
Session Title: What's the Point of Screening for HCC? (BE19)
Presenter: Jorge A. Marrero
Learning Objectives: Participants will be able to:

Identify the patients that benefit from surveillance for HCC.

Identify the tests for the surveillance for HCC.

To review the data on surveillance for HCC.